Cargando…
Copper (II) Metallodendrimers Combined with Pro-Apoptotic siRNAs as a Promising Strategy Against Breast Cancer Cells
Cancer treatment with small interfering RNA (siRNA) is one of the most promising new strategies; however, transfection systems that increase its bioavailability and ensure its delivery to the target cell are necessary. Transfection systems may be just vehicular or could contain fragments with antica...
Autores principales: | Sanz del Olmo, Natalia, Holota, Marcin, Michlewska, Sylwia, Gómez, Rafael, Ortega, Paula, Ionov, Maksim, de la Mata, Francisco Javier, Bryszewska, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464408/ https://www.ncbi.nlm.nih.gov/pubmed/32748821 http://dx.doi.org/10.3390/pharmaceutics12080727 |
Ejemplares similares
-
In Vitro Anticancer Properties of Copper Metallodendrimers
por: Hołota, Marcin, et al.
Publicado: (2019) -
Combination of Copper Metallodendrimers with Conventional Antitumor Drugs to Combat Cancer in In Vitro Models
por: Hołota, Marcin, et al.
Publicado: (2023) -
Complexes of Pro-Apoptotic siRNAs and Carbosilane Dendrimers: Formation and Effect on Cancer Cells
por: Krasheninina, Olga A., et al.
Publicado: (2019) -
Ruthenium Dendrimers against Human Lymphoblastic Leukemia 1301 Cells
por: Michlewska, Sylwia, et al.
Publicado: (2020) -
Synthesis and Characterization of FITC Labelled Ruthenium Dendrimer as a Prospective Anticancer Drug
por: Michlewska, Sylwia, et al.
Publicado: (2019)